TDL VeriSeq V2 Illumina NIPT in London

Came here looking for the Harmony test? TDL — The Doctors Laboratory in London — was the UK provider of Harmony, and withdrew it in September 2023 at roughly two weeks’ notice. TDL VeriSeq V2 is the Illumina assay the same laboratory runs in its place: same London laboratory, newer sequencing technology.

£540 including your expert ultrasound scan, with results typically in 2-4 working days from a UK laboratory. NIPT is a screening test, not a diagnostic one. New to NIPT? Compare all our NIPT tests or see the full NIPT price list.

TDL VeriSeq V2 Illumina NIPT in London

TDL VeriSeq V2 is a non-invasive prenatal test (NIPT) run by TDL — The Doctors Laboratory — at its genetics laboratory in London. It uses the Illumina VeriSeq NIPT Solution v2 assay, a whole-genome sequencing platform, to screen for the three most common chromosomal conditions in pregnancy from 10 weeks.

At London Pregnancy Clinic we offer it as a package with an expert early ultrasound for £540 — every NIPT we provide includes the scan. Results normally reach us in 2-4 working days. Your scan is performed by an experienced sonographer or clinician and interpreted by our specialist fetal medicine clinicians, and every result is reviewed and authorised by a clinician before we contact you.

Because the laboratory is in London, your sample does not cross a border: there is no international courier leg and no customs delay, so turnaround is shorter than for tests processed overseas. That is one practical reason we keep a UK-processed test on our NIPT menu. To see how it sits alongside PrenatalSAFE, Panorama and our extended panels, our best NIPT test in London comparison sets them out side by side.

3D ultrasound of a 10-week baby with DNA helix illustration representing TDL VeriSeq V2 NIPT screening
TDL VeriSeq V2 pairs UK-processed genetic screening with an expert early ultrasound from 10 weeks

VeriSeq V2 at a glance

The essentials in one place. The package we offer is a basic NIPT panel — deliberately focused on the three common trisomies rather than an extended list of rarer conditions.

  • Screens for Down’s syndrome (trisomy 21), Edwards’ syndrome (trisomy 18) and Patau’s syndrome (trisomy 13)
  • Optional fetal sex determination, reported only if you want to know
  • Runs on the Illumina VeriSeq NIPT Solution v2 assay — a whole-genome sequencing approach to NIPT
  • Processed by TDL (The Doctors Laboratory) in London, so your sample stays in the UK
  • Available from 10 weeks of pregnancy, with your dates confirmed by ultrasound on the day
  • Results typically in 2-4 working days, though turnaround is not guaranteed
  • £540 with an expert ultrasound scan included
  • One maternal blood sample — the test itself carries no physical risk to your baby
  • Run by the laboratory that provided the Harmony test in the UK until September 2023
  • A screening test, not a diagnostic one: a higher-chance result needs confirming by CVS or amniocentesis
  • Our package does not include microdeletions, 22q11.2 (DiGeorge) syndrome or single-gene disorders

TDL VeriSeq V2 key facts

£540 With an expert ultrasound scan included
2-4 days Typical turnaround in working days once the laboratory receives your sample; not guaranteed
10 weeks The earliest gestation at which the assay is validated, confirmed by scan on the day
T21, T18, T13 The three chromosomal conditions our package screens, plus optional fetal sex determination
London Processed by TDL (The Doctors Laboratory) at its genetics laboratory in London
1 tube A single maternal blood sample is all the laboratory needs to run the test

Why VeriSeq V2 is the successor to Harmony

For about a decade the Harmony test was the NIPT most UK patients had heard of, and TDL was the laboratory that ran it here — Ariosa Diagnostics announced the UK distribution partnership with The Doctors Laboratory in January 2013. When TDL withdrew Harmony in September 2023, at roughly two weeks’ notice, a great many women who had been told to book ‘the Harmony test’ could no longer book it at TDL.

TDL VeriSeq V2 is what the laboratory runs in its place. The laboratory is the same, the London address is the same and the clinical pathway is the same. What changed is the assay underneath. Harmony used a targeted cell-free DNA method that counted fragments from a small number of selected chromosomes. VeriSeq V2 uses whole-genome sequencing: fragments from across the entire genome are sequenced and mapped, and the software looks at how many land on each chromosome.

The clinical purpose is unchanged. Both tests screen for the same three trisomies from a single maternal blood sample, both report optional fetal sex, and neither is diagnostic. If you were referred specifically for Harmony, TDL VeriSeq V2 is simply the test TDL now runs in its place — the closest like-for-like option if what mattered to you was that same London laboratory.

If you have no particular attachment to TDL, PrenatalSAFE is our default basic NIPT at the same £540, and it is the option validated for vanishing twin pregnancies. Our Harmony test alternatives page sets both out alongside Panorama and UNITY, so you can see the full picture before deciding.

TDL VeriSeq V2 explained

Non-invasive prenatal testing works by analysing cell-free DNA (cfDNA) — short fragments of DNA that pass from the placenta into the mother’s bloodstream. From around 10 weeks of pregnancy there is usually enough of this placental DNA circulating for a laboratory to assess whether the chromosome counts look typical.

TDL VeriSeq V2 does this using the Illumina VeriSeq NIPT Solution v2, a whole-genome sequencing approach to non-invasive prenatal testing. Rather than targeting a handful of chromosomes, it sequences fragments from across the whole genome and counts how many map to each one. An excess of fragments mapping to chromosome 21, for example, indicates a higher chance of Down’s syndrome.

The workflow is heavily automated — Illumina states that a run goes from sample to report in approximately 26 hours, though that is laboratory processing time rather than the time you wait. Your result normally reaches us within 2-4 working days, and a clinician reviews and authorises it before anyone calls you. If the terminology below is unfamiliar, our guide to NIPT results explained walks through it in plain language.

3D ultrasound image from a first-trimester scan at around 12 weeks, illustrating the ultrasound paired with TDL VeriSeq V2 NIPT
A first-trimester 3D image from around 12 weeks — every NIPT at London Pregnancy Clinic is paired with an expert ultrasound
01

A single blood sample

The test needs one tube of blood from your arm, taken in the same way as any routine antenatal blood test. There is no needle near the pregnancy and no procedural risk to your baby — that is what ‘non-invasive’ means in this context.

What the laboratory measures is the fetal fraction: the proportion of the cfDNA in your sample that comes from the placenta rather than from you. Below about 10 weeks that proportion is often too low for a reliable analysis, which is why the assay is validated from 10 weeks onwards and why TDL states that it tests pregnancies of at least 10 weeks’ gestation.

Fetal fraction also tends to be lower at higher maternal body weight. If it is too low on the first draw, the result comes back as a ‘no call’ and a second sample is needed, rather than a wrong answer being reported.

02

What our package screens for

Fetal sex determination is optional and included in the price. We only report it if you have asked us to, and we check again on the day before your result is prepared.

The panel we offer through TDL is a basic NIPT panel covering the three trisomies that account for the great majority of chromosomal conditions found in the first trimester:

  • Down’s syndrome (trisomy 21) — an extra copy of chromosome 21
  • Edwards’ syndrome (trisomy 18) — an extra copy of chromosome 18
  • Patau’s syndrome (trisomy 13) — an extra copy of chromosome 13
  • Fetal sex (optional, at your request)
03

Published performance figures

In the manufacturer’s validation of the VeriSeq NIPT Solution v2 assay, the basic screening analysis correctly classified every confirmed case of each of the three trisomies once known mosaic cases were excluded, with specificity of 99.90 per cent and six false-positive results across the three conditions (Pertile et al., Clinical Chemistry, 2021).

Validation cohorts are deliberately enriched with affected pregnancies, so these figures show the assay performing as intended rather than predicting what any individual should expect. The trisomy 18 and trisomy 13 estimates rest on small numbers of confirmed cases, and the confidence intervals below show how much uncertainty that leaves: the true sensitivity for those two conditions could be meaningfully lower than the point estimate.

For a population-level view, a systematic review and meta-analysis of cell-free DNA screening reported pooled detection rates of 99.3 per cent for trisomy 21 and 97.4 per cent for trisomies 18 and 13, with specificity of 99.9 per cent or above in each case (Taylor-Phillips et al., BMJ Open, 2016).

None of this makes NIPT diagnostic. What matters for your own result is the positive predictive value, which also depends on how likely the condition was before you tested — largely a function of maternal age. Our NIPT PPV calculator shows how the same test result can mean very different things at different ages.

The published figures for the basic screen were:

  • Trisomy 21 — 130 of 130 confirmed cases classified correctly; sensitivity above 99.9% (95% CI 97.1-100%)
  • Trisomy 18 — 41 of 41 confirmed cases classified correctly; sensitivity above 99.9% (95% CI 91.4-100%)
  • Trisomy 13 — 26 of 26 confirmed cases classified correctly; sensitivity above 99.9% (95% CI 87.1-100%)
  • Specificity 99.90% for each of the three trisomies, with six false-positive results in total
  • 1.2% of samples failed quality control at first pass — a laboratory QC figure from that validation cohort, not a service-level no-call rate for TDL
04

Who the test is suitable for

TDL tests pregnancies from 10 weeks of gestation, in singleton and twin pregnancies, whether conceived naturally or through IVF.

We check suitability at your appointment. If anything in your history or on your scan means NIPT is not the right test, we will tell you before any blood is taken rather than after.

A few situations need a conversation before you book:

  • Illumina states the assay is not validated for pregnancies with more than two babies, so triplets and higher-order multiples are outside its scope
  • A vanishing twin can contaminate the sample with DNA from the non-developing pregnancy and needs a platform validated for it
  • A maternal history of malignancy, or a bone marrow or organ transplant, can make cfDNA results unreliable
  • Where a scan has already shown a structural anomaly or increased nuchal translucency, a diagnostic test is usually more appropriate than screening
  • In twins, fetal sex is reported as a single result for the pair rather than individually
05

How your appointment works

Your scan comes first. A specialist fetal medicine clinician or advanced sonographer confirms that the pregnancy is viable, dates it accurately and establishes how many babies there are. We confirm all three before the blood draw, because the laboratory needs them to run and interpret the result correctly.

At the same visit we look at how your baby is developing. Even at 10 weeks a considerable amount of early structure can be assessed, and if anything needs attention we would discuss it with you before the blood draw — because NIPT is not the right test when a structural anomaly is suspected.

A phlebotomist then takes a single tube of blood from your arm. It travels by secure medical courier to TDL’s genetics laboratory in London the same day.

Results normally reach us within 2-4 working days. A clinician reviews and authorises them, and a member of our clinical team then telephones you to explain what they mean. Your scan report is delivered securely through our cloud platform, Tricefy. You can book online or check the full fees list first.

06

Why an ultrasound is part of the test

The scan is not an optional extra bundled in for value. Confirmed viability, accurate gestational age and the number of babies are needed for every NIPT sample, and only ultrasound can provide them.

There is a clinical reason too. NIPT screens for chromosomal conditions and cannot show how a baby is physically formed. In England in 2022, congenital conditions of all kinds were registered in 255.0 of every 10,000 births, against 30.2 per 10,000 for Down’s syndrome — about one in 331 births (NCARDRS, 2022). Structural differences of the heart, brain, abdominal wall and spine are collectively far more common than Down’s syndrome, and no blood test will find them.

Our early scanning is built around exactly that gap. Most patients have VeriSeq V2 alongside our 10 week scan; an early fetal scan at 15-16 weeks gives a fuller structural assessment, and a nuchal scan at 11-14 weeks remains valuable in its own right.

What our TDL VeriSeq V2 package does not include

The package we offer covers trisomy 21, trisomy 18 and trisomy 13, with optional fetal sex determination. Some of that is a deliberate choice on our part rather than a limit of the technology. TDL also offers an optional sex chromosome panel alongside this assay, and the Illumina platform can be run as a wider genome-wide analysis.

We do not include either as standard, because cell-free DNA screening for sex chromosome conditions has more limited validation and a higher false-positive rate than trisomy screening, and we would rather discuss it with you than report it by default. If you would like it, please tell us before you book.

Other things are genuinely outside what this test can do. 22q11.2 deletion syndrome (DiGeorge syndrome) involves a deletion of roughly 3 Mb, below the 7 Mb resolution Illumina states even for the genome-wide analysis, so it is not detectable by this assay. The following are not covered by our package:

  • 22q11.2 deletion (DiGeorge) syndrome and other microdeletions or microduplications
  • Sex chromosome aneuploidies such as Turner syndrome (45,X) and Klinefelter syndrome (47,XXY) — optional at TDL, but not part of our standard package
  • Single-gene (monogenic) disorders such as cystic fibrosis, achondroplasia and Noonan syndrome
  • Structural anomalies such as heart defects, spina bifida or cleft lip — these are found on ultrasound, not by any NIPT
  • Rare autosomal trisomies other than 21, 18 and 13
  • Triploidy and molar pregnancy

If you would like wider coverage, Panorama adds sex chromosome conditions, triploidy and 22q11.2 deletion, and the SMART Test is our most extensive package, covering microdeletions and a large panel of genetic syndromes alongside a comprehensive ultrasound. PrenatalSAFE Complete Plus is a further extended option, and extended NIPT in London explains how the wider panels differ.

A broader panel is not automatically a better one. Screening for rarer conditions also produces more results that need following up, some of which turn out to be nothing — which is precisely why we do not add sex chromosome reporting as standard. If you would like to think that through with a specialist before choosing, NIPT genetic counselling is available.

Comparison

Your NIPT options – Comparison Table

How our TDL VeriSeq V2 package compares with our other NIPT options. Each row describes the package we offer, not the maximum capability of the laboratory behind it. Turnaround times are typical working days from the laboratory receiving your sample and are not guaranteed. Full details for each test are on its own page — see PrenatalSAFE, Panorama and the SMART Test.

FeatureTDL VeriSeq V2PrenatalSAFEPanorama AISMART Test
PanelBasicBasic extendedMost advanced
Laboratory locationUKUSUK + EU
Available from10 weeks9 weeks10 weeks
Turnaround (working days)2-57-107-10
Down’s, Edwards’ & Patau’s
Fetal sex (optional)
Sex chromosome aneuploidies
DiGeorge syndrome (22q del)
Microdeletions112
Single-gene disorders
Twin pregnanciesWithout 22q del
Scan & NIPT price£540£590 (£790 with microdeletions)from £990

Prices shown are for the NIPT together with our ultrasound scan — every NIPT we offer includes it.

We have not given no-call or redraw percentages in this table. Published no-call rates for cell-free DNA screening generally fall in the region of 1-3%, but TDL does not publish a service-level figure for VeriSeq V2, and comparing manufacturers’ validation numbers with real-world service rates would not be a like-for-like comparison.

Understanding your result

NIPT is a screening test, not a diagnostic one. A ‘low chance’ result is strong reassurance about the three conditions screened, but it is not a guarantee, and it says nothing about the many conditions the test does not look for. A ‘high chance’ result means the chance is raised — it is not a diagnosis.

Every result is reviewed and authorised by a clinician before we contact you, and we telephone rather than emailing a number without context. If the result is high chance we will talk it through with you promptly and arrange NIPT genetic counselling, so you have time and support before deciding anything.

Confirming a high-chance result means a diagnostic test: chorionic villus sampling (CVS), usually from around 11-12 weeks, or amniocentesis from around 15-16 weeks. Both sample the pregnancy directly so the laboratory can perform a karyotype or chromosome analysis and give a definitive answer. Both also carry a small risk of miscarriage, which is why they follow a screening result rather than replacing one. RCOG guidance is clear that results should be given in a non-directive way and that whatever you decide should be respected.

How likely a high-chance result is to be correct depends on your background chance as well as on the test itself — this is the positive predictive value. You can explore it for your own circumstances with our NIPT PPV calculator, and read about the conditions themselves on our Down’s syndrome, Edwards’ syndrome and Patau’s syndrome pages.

We would also encourage you to keep your NHS antenatal appointments alongside private screening. NHS combined screening at 11-14 weeks and your midwife’s continuity of care remain important whichever private test you choose.

Important

This information is intended for general educational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional for guidance specific to your individual circumstances. If you have concerns about your pregnancy or your baby’s wellbeing, contact your midwife, GP or maternity unit promptly.

Your questions answered

TDL VeriSeq V2 — your questions answered

Is the TDL VeriSeq V2 test the same as the Harmony test?

No — they are different tests from the same laboratory. TDL (The Doctors Laboratory) was the UK provider of the Harmony test for around a decade, from the distribution partnership announced in January 2013 until it withdrew the test in September 2023, at roughly two weeks’ notice. TDL VeriSeq V2 is the test it now runs in Harmony’s place.

What the two share is the laboratory, the London location and the clinical purpose: screening for Down’s, Edwards’ and Patau’s syndromes from a single maternal blood sample, with optional fetal sex determination. What differs is the technology underneath. Harmony used a targeted cell-free DNA method; VeriSeq V2 uses the Illumina VeriSeq NIPT Solution v2, a whole-genome sequencing assay.

If you were referred specifically for Harmony, this is the test TDL now runs in its place. Our Harmony test page explains the background, and Harmony test alternatives lists everything we now offer instead.

How accurate is the VeriSeq V2 NIPT test?

In the manufacturer’s validation of the VeriSeq NIPT Solution v2 assay, and excluding known mosaic cases, the basic screening analysis correctly classified 130 of 130 confirmed trisomy 21 samples, 41 of 41 trisomy 18 samples and 26 of 26 trisomy 13 samples. Sensitivity was above 99.

9 per cent for each, but with wide confidence intervals reflecting the small number of confirmed cases — 95% CI 97.1-100% for trisomy 21, 91.4-100% for trisomy 18 and 87.1-100% for trisomy 13. Specificity was 99.90 per cent for each, with six false-positive results in total, and 1.2 per cent of samples failed quality control at first pass (Pertile et al.

, Clinical Chemistry, 2021).

Validation cohorts are deliberately enriched with affected pregnancies, so those figures are best read as evidence that the assay works as intended rather than as the numbers you should expect personally. In routine populations, a systematic review and meta-analysis of cell-free DNA screening reported pooled detection rates of 99.3 per cent for trisomy 21 and 97.4 per cent for trisomies 18 and 13, with specificity of 99.9 per cent or above (Taylor-Phillips et al., BMJ Open, 2016).

Accuracy is not the same as certainty, and no NIPT is diagnostic. What determines the meaning of your own result is the positive predictive value, which also depends on your background chance — our NIPT PPV calculator illustrates this, and NIPT results explained covers the terminology.

How long do TDL VeriSeq V2 results take?

Results usually reach us in 2-4 working days from the laboratory receiving your sample. TDL’s own wording is that results are ready in approximately 2-4 days, so treat this as a typical turnaround rather than a guarantee.

The main reason it is quick is geography. TDL’s genetics laboratory is in London, so your sample travels across the city by medical courier rather than by international freight — considerably faster than tests processed in the United States. The Illumina workflow itself is highly automated and, according to the manufacturer, goes from sample to report in approximately 26 hours once a run begins.

If a sample needs repeating — most often because there was not enough placental DNA in the first draw — a second sample adds a few days. We contact you as soon as a clinician has reviewed and authorised your result.

How much does the TDL VeriSeq V2 test cost in London?

£540 for the test together with an expert ultrasound scan at our London clinic — the scan is part of every NIPT we offer. That is the same price as our PrenatalSAFE package, which screens for the same three conditions.

Because the two are priced the same and cover the same conditions, the choice between them is not about money. TDL VeriSeq V2 is the one to pick if you were referred for Harmony or want the same TDL laboratory; PrenatalSAFE is our default otherwise, and it is the option validated for vanishing twin pregnancies.

The £540 package covers the scan, the blood draw, the laboratory fee, clinician review of your result and a telephone call to explain what it means. Optional fetal sex determination is included rather than charged as an extra. You can see how this compares with our other tests on the NIPT cost in the UK page or our full fees list, and book online when you are ready.

Can I have the VeriSeq V2 test with twins?

Yes. TDL tests twin pregnancies with VeriSeq V2 from 10 weeks, whether conceived naturally or through IVF.

There are two things to be aware of. Fetal sex is reported as a single result covering both babies rather than one result each, so the test cannot tell you that one twin is a boy and the other a girl. And because two placentas contribute cell-free DNA, screening performance in twins is generally less well established than in singleton pregnancies.

A vanishing twin — where one twin has stopped developing — is a different situation, and not every NIPT platform is validated for it. Please tell us before booking; PrenatalSAFE is the option we would normally discuss in that circumstance. Illumina states the assay is not validated for pregnancies with more than two babies, so triplets and higher-order pregnancies are outside its scope.

Is the VeriSeq V2 test processed in a UK laboratory?

Yes. TDL — The Doctors Laboratory — runs the assay at its genetics laboratory in London, on Illumina sequencing instruments.

For patients this mainly means speed and traceability. Your sample goes by courier across London rather than crossing a border, so there is no international shipping leg and no customs delay, and if a query arises the laboratory is in the same city and the same time zone as the clinicians looking after you.

TDL is one of the largest independent clinical laboratories in the UK and has provided prenatal screening to British clinics for many years, including the decade during which it ran the Harmony test.

From how many weeks can I have the VeriSeq V2 test?

From 10 weeks of pregnancy. The assay is validated in pregnancies of at least 10 weeks’ gestation, and TDL tests from that point.

We confirm your dates by ultrasound on the day rather than relying on your last menstrual period, because being even a few days early can mean the sample cannot be run. If you are unsure how far along you are, a viability scan at around 7-8 weeks will date the pregnancy so we can book your NIPT for exactly the right day.

Most people have the test alongside our 10 week scan. If you are already further on, NIPT can still be performed later in pregnancy, and an early fetal scan at 15-16 weeks or a nuchal scan at 11-14 weeks may be the more useful scan to pair it with. Testing in the first trimester is generally preferable, as it leaves the most time for any follow-up.

Does the VeriSeq V2 test screen for DiGeorge syndrome or microdeletions?

No. The package we offer covers trisomy 21, trisomy 18 and trisomy 13, with optional fetal sex determination. It does not include microdeletions, 22q11.2 deletion syndrome (DiGeorge syndrome) or single-gene disorders. 22q11.2 deletion is around 3 Mb, below the 7 Mb resolution Illumina states even for the assay’s genome-wide analysis, so it is not detectable by this test.

Sex chromosome conditions are a slightly different case. TDL offers an optional sex chromosome panel alongside this assay, but we do not include it as standard, because cell-free DNA screening for those conditions has more limited validation and a higher false-positive rate than trisomy screening. If you would like it, tell us before you book so we can talk it through first.

If you want broader coverage, Panorama adds sex chromosome aneuploidies, triploidy and 22q11.2 deletion, while the SMART Test is our most extensive package. There is no single right answer, and a broader panel is not automatically better — wider screening also generates more findings that need following up. NIPT genetic counselling is available if you would like a longer conversation, and you can compare every option on our best NIPT test in London page.

What happens if my result comes back as a ‘no call’?

A ‘no call’ means the laboratory could not produce a reliable result from your sample, most often because the fetal fraction — the proportion of cell-free DNA coming from the placenta — was too low to analyse. In the manufacturer’s validation of the assay, 1.2 per cent of samples failed quality control at first pass, although that is a laboratory figure from a validation cohort rather than a service-level rate for TDL.

It is not a result in itself, and it is not an indication that anything is wrong. Fetal fraction rises as pregnancy progresses and tends to be lower at higher maternal body weight, so the usual next step is a second blood sample taken a week or two later, which resolves most cases.

We will call you to explain what happened, arrange the repeat sample and set out anything you need to know about timing or cost before you decide. If a second attempt is also unsuccessful, we would talk through the alternatives with you — a different NIPT platform, NHS combined screening, or a diagnostic test if your circumstances warrant it.

Can I have the test if I conceived with donor eggs or through surrogacy?

Please tell us before you book. Cell-free DNA testing analyses placental DNA, so a donor egg or surrogate pregnancy does not prevent screening in principle, but not every platform is validated for every situation and the laboratory needs to know in advance to interpret the result correctly.

PrenatalSAFE is the option we most often use for donor egg and surrogacy pregnancies, and it is the same £540 with our scan. If you would prefer the TDL laboratory, we will confirm suitability with TDL before your appointment rather than after your blood has been taken.

Fetal sex determination is unaffected by how the pregnancy was conceived. If you are also considering a wider panel, extended NIPT in London sets out which of our tests cover which situations.

Do I still need NHS screening if I have TDL VeriSeq V2?

Private NIPT is an addition to NHS antenatal care, not a replacement for it. We would always encourage you to keep your NHS appointments, your midwife’s continuity of care and your NHS anomaly scan at around 20 weeks, whichever private test you choose.

NHS combined screening at 11-14 weeks uses a nuchal translucency measurement together with blood markers and your age to estimate the chance of Down’s, Edwards’ and Patau’s syndromes. NIPT is more accurate for those three conditions, but the nuchal measurement itself carries information that a blood test does not — a raised nuchal translucency can point towards cardiac and other structural problems regardless of the chromosomes.

That is why we pair every NIPT with ultrasound, and why a nuchal scan at 11-14 weeks remains worth having in its own right. If a private result is high chance, we will help you bring it into your NHS pathway promptly so that any diagnostic testing and specialist care are arranged without delay.

I’m not based in London — can I just do the NIPT without a scan?

Not through London Pregnancy Clinic — every NIPT we offer includes an expert ultrasound scan. The scan confirms your pregnancy is viable, dates it accurately and checks it is suitable for testing, which is why we do not offer the blood test on its own.

If you cannot get to our London clinic, our partner Jeen Health offers NIPT across the UK. You will need to provide proof of a pregnancy scan taken within the last 7 days before your blood sample is taken.

Contact

Do you want to know more about your options of NIPT?

Send us an enquiry

A clinician will reply within one working day.

For urgent matters please call 020 3687 2939.

Sources & clinical references

The figures and clinical statements on this page are drawn from the sources below. Guidance evolves — always discuss your individual circumstances with a clinician.

  1. IlluminaVeriSeq NIPT Solution v2 — product overview (basic screen reports trisomy status for chromosomes 21, 18, 13, X and Y; genome-wide screen resolves deletions/duplications of ≥7 Mb; validated from at least 10 weeks’ gestation)Accessed July 2026
  2. TDL — The Doctors LaboratoryNon-invasive prenatal testing (NIPT) — VeriSeq NIPT Solution v2, TDL Genetics, London (results in approximately 2-4 days; optional sex chromosome panel; pregnancies of at least 10 weeks’ gestation)Accessed July 2026
  3. BMJ Open (Taylor-Phillips S et al., University of Warwick)Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis2016
  4. PR Newswire / Ariosa DiagnosticsAriosa Diagnostics Announces Partnership with The Doctors Laboratory (TDL) to Distribute the Harmony Prenatal Test in the UK2013
  5. NHS England Digital (NCARDRS)NCARDRS Congenital Condition Statistics Report, 2022 — birth prevalence of congenital conditions and of Down’s, Edwards’ and Patau’s syndromes in England2022
  6. NHSScreening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome2024
  7. RCOGSupporting women and their partners through prenatal screening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome (consensus statement)2020